Blog
Keep up to date with the latest news from Instem.
The Changing Language of Clinical Trial Transparency
This blog examines how clinical trial transparency regulations are evolving and what organizations can do to keep up with expectations.
Webinar Recap: Closing Compliance Gaps with Compliance Builder
Comprehensive electronic recordkeeping is a cornerstone of all laboratory functions in regulated industries, but establishing and maintaining 21 CFR Part 11 compliance is challenging when processes are fragmented across multiple instruments and systems.
Advancing Risk-Based E&L Safety Assessment: The Role of ICH Q3E and Leadscope
As ICH Q3E advances a risk-based paradigm for E&L safety, the question is shifting from whether to assess risk toward how to do it consistently across a vast and diverse chemical space. Leadscope enables structure...
Enhanced Physiological Data Analysis with Advanced Sleep and Signal Processing Capabilities with NOTOCORD‑hem 5.3
Version 5.3 introduces new modules for automated and validated sleep analysis alongside improved signal processing and reporting, supporting robust and compliant physiological research.
Accelerating Non-GLP Drug Discovery with BioRails
From preparation to analysis and reporting, BioRails actively supports the entire experimental workflow.
Why QC Laboratories Can’t Afford Blind Spots in Their File Systems
FDA Form 483 observations related to data integrity remain a persistent issue for the industry, and the consequences for a lab are significant.
Instem Interact 2026 – A Resounding Success
Turning Insight into Innovation in Preclinical R&D
Leadscope Model Applier™ v2026 – Expanding confidence in predictive toxicology
This release introduces advanced predictive models and extensive toxicological data to support rigorous chemical safety assessments.
What the FDA Webcast Revealed About SEND (and Why It Matters)
“For the first time, the FDA openly acknowledged that they are rejecting some SEND datasets because the quality isn’t good enough. No ambiguity. Just a clear statement that quality matters, and that poor SEND has...
